Literature DB >> 17611689

Clinical significance of the loss of MATS1 mRNA expression in colorectal cancer.

Yoshimasa Kosaka1, Koshi Mimori, Fumiaki Tanaka, Hiroshi Inoue, Masahiko Watanabe, Masaki Mori.   

Abstract

Human Mob as tumor suppressor 1 (MATS1) has been shown to play a crucial role in tumor growth by regulating cell proliferation and apoptosis. We evaluated the expression of MATS1 in colorectal cancer patients and assessed its clinicopathological significance. MATS1 mRNA expression in paired tumor/normal samples from 72 cases of colorectal cancer was evaluated, using real-time RT-PCR analysis. MATS1 protein expression was determined by immunohistochemical staining. MATS1 mRNA expression was significantly lower in tumor tissues than in normal colorectal tissues (p<0.05). Clinicopathologically, factors such as incidence of large tumor size, deep invasion, lymphatic permeation and liver metastasis were significantly more frequent in the low MATS1 expression group (p<0.05). Prognosis of the low expression group tended to be poorer than that of the high expression group. MATS1 protein expression was diminished in tumor cells compared with corresponding non-cancer colon epithelial cells. MATS1 mRNA expression is suppressed in tumor tissue and its low expression is associated with tumor growth, invasion and metastasis of colorectal cancer. Specifically, low MATS1 expression may be a good marker of liver metastasis, a life-threatening indicator for colorectal cancer patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17611689

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  11 in total

Review 1.  Snapshots of a hybrid transcription factor in the Hippo pathway.

Authors:  Xuelian Luo
Journal:  Protein Cell       Date:  2010-10-07       Impact factor: 14.870

2.  The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version.

Authors:  Bin Zhao; Li Li; Qunying Lei; Kun-Liang Guan
Journal:  Genes Dev       Date:  2010-05       Impact factor: 11.361

3.  Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice.

Authors:  Miki Nishio; Koichi Hamada; Kohichi Kawahara; Masato Sasaki; Fumihito Noguchi; Shuhei Chiba; Kensaku Mizuno; Satoshi O Suzuki; Youyi Dong; Masaaki Tokuda; Takumi Morikawa; Hiroki Hikasa; Jonathan Eggenschwiler; Norikazu Yabuta; Hiroshi Nojima; Kentaro Nakagawa; Yutaka Hata; Hiroshi Nishina; Koshi Mimori; Masaki Mori; Takehiko Sasaki; Tak W Mak; Toru Nakano; Satoshi Itami; Akira Suzuki
Journal:  J Clin Invest       Date:  2012-11-12       Impact factor: 14.808

4.  Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice.

Authors:  Miki Nishio; Keishi Sugimachi; Hiroki Goto; Jia Wang; Takumi Morikawa; Yosuke Miyachi; Yusuke Takano; Hiroki Hikasa; Tohru Itoh; Satoshi O Suzuki; Hiroki Kurihara; Shinichi Aishima; Andrew Leask; Takehiko Sasaki; Toru Nakano; Hiroshi Nishina; Yuji Nishikawa; Yoshitaka Sekido; Kazuwa Nakao; Kazuo Shin-Ya; Koshi Mimori; Akira Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-22       Impact factor: 11.205

Review 5.  MOB control: reviewing a conserved family of kinase regulators.

Authors:  Alexander Hergovich
Journal:  Cell Signal       Date:  2011-04-21       Impact factor: 4.315

6.  Hippo pathway-related genes expression is deregulated in myeloproliferative neoplasms.

Authors:  Maira da Costa Cacemiro; Juçara Gastaldi Cominal; Luiz Miguel Pereira; Maria Gabriela Berzoti-Coelho; Giovana Michelassi Berbel; Luciana Baroni; Tathiane Malta; Raquel Tognon; Natalia de Souza Nunes; Elizabeth Xisto Souto; Lorena Lobo de Figueiredo-Pontes; Ana Patricia Yatsuda; Fabíola Attié de Castro
Journal:  Med Oncol       Date:  2022-05-23       Impact factor: 3.064

7.  YAP1 and PRDM14 converge to promote cell survival and tumorigenesis.

Authors:  Miju Kim; Seav Huong Ly; Yingtian Xie; Gina N Duronio; Dane Ford-Roshon; Justin H Hwang; Rita Sulahian; Jonathan P Rennhack; Jonathan So; Ole Gjoerup; Jessica A Talamas; Maximilien Grandclaudon; Henry W Long; John G Doench; Nilay S Sethi; Marios Giannakis; William C Hahn
Journal:  Dev Cell       Date:  2022-01-05       Impact factor: 12.270

Review 8.  The hippo signaling pathway in development and cancer.

Authors:  Duojia Pan
Journal:  Dev Cell       Date:  2010-10-19       Impact factor: 12.270

9.  "Stealth dissemination" of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinoma.

Authors:  Gary A Clawson; Gail L Matters; Ping Xin; Christopher McGovern; Eric Wafula; Claude dePamphilis; Morgan Meckley; Joyce Wong; Luke Stewart; Christopher D'Jamoos; Naomi Altman; Yuka Imamura Kawasawa; Zhen Du; Loren Honaas; Thomas Abraham
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

Review 10.  Emerging role of Hpo signaling and YAP in hepatocellular carcinoma.

Authors:  Vicente Valero; Timothy M Pawlik; Robert A Anders
Journal:  J Hepatocell Carcinoma       Date:  2015-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.